Transcatheter mitral and tricuspid technologies Critical care technologies* Surgical valve technologies *Edwards Lifesciences Critical Care is now part of BD (Becton, Dickinson and …

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence …

Edwards Lifesciences is committed to providing reasonable accommodations and adjustments to individuals with a disability or neurodivergence. If you need an accommodation or adjustment …

Jul 24, 2024 · Edwards has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), a deadly disease that …

Our locations With more than 16,000 employees across the globe, we celebrate our inclusive culture and embrace the diverse perspectives and experiences of our Edwards team. No …

About us Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.

Apr 14, 2025 · “We were the first to gain CE Mark for a transcatheter tricuspid valve replacement system, and with the SAPIEN M3 system’s approval, Edwards is now the only company …

Headquartered in Irvine, California, our teams work together to create a sense of community and are focused on supporting what is best for Edwards and the patient.

Who we are Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.

Building from Edwards’ foundation rooted in the company’s Credo, the patient-focused culture and the unique innovation strategy, Zovighian and the global Edwards employees are united and …